Hormone Resistant Prostate Cancer Terminated Phase 1 Trials for Fluorine F-18 (DB13134)

Also known as: Hormone-Resistant Prostate Cancer

IndicationStatusPhase
DBCOND0038482 (Hormone Resistant Prostate Cancer)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02429804NaF/FDG PET/MRI in Measuring Response to Radium Ra 223 Dichloride in Patients With Metastatic Hormone-Resistant Prostate CancerDiagnostic